Abstract
Patients with cystic fibrosis can develop multi-resistant organisms and may have poor intravenous access making antibiotic treatment difficult. This case discusses the successful use of fosfomycin via the subcutaneous route in a paediatric patient with cystic fibrosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have